SARS-CoV-2 neutralizing antibody epitopes are overlapping and highly mutated which raises the chances of escape variants and requires development of broadly reactive vaccines.

Joseph, Jeswin; Darpe, Sukhada; Kulkarni, Grishma; Raj, V Stalin

Joseph, Jeswin; Darpe, Sukhada; Kulkarni, Grishma; Raj, V Stalin.

Afiliação

Joseph J; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.
Darpe S; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.
Kulkarni G; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.
Raj VS; Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.

Proteins ; 91(8): 1021-1031, 2023 08.

Article em En | MEDLINE | ID: mdl-36912191

Assuntos

COVID-19; SARS-CoV-2; Humanos; SARS-CoV-2/genética; Epitopos/genética; Anticorpos Neutralizantes; COVID-19/prevenção & controle; Anticorpos Monoclonais/genética; Anticorpos Antivirais

Palavras-chave

SARS-CoV-2; delta variant; epitopes; monoclonal antibodies; omicron variant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article